← All companies

CCCC

C4 Therapeutics, Inc.

CCCC Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$3.59

-0.02 -0.55%

Key statistics

from XBRL data in SEC filings

Market cap

$397M

Revenue (TTM)

$34.9M

Net income (TTM)

-$104M

EPS (TTM)

$-1.10

P/E ratio

—

Dividend yield

—

Free cash flow

-$99.3M

Cash

$61.3M

Total assets

$329M

Gross margin

—

52-week range

$1.69 – $5.17

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 24, 2026 8-K Regulation FD disclosure; Other events Jun 11, 2026 8-K Director or officer change May 15, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 8-K Amended charter or bylaws Apr 10, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Jan 14, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement Oct 16, 2025 8-K Other events Oct 16, 2025 8-K Regulation FD disclosure; Other events Oct 1, 2025 8-K Regulation FD disclosure; Other events Sep 22, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Aug 7, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 7, 2025 8-K Director or officer change Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 14, 2025 8-K Other events Dec 9, 2024 8-K Director or officer change; Regulation FD disclosure Nov 20, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K/A Director or officer change; Regulation FD disclosure Oct 16, 2024 8-K Director or officer change; Regulation FD disclosure Oct 15, 2024 8-K Director or officer change Oct 11, 2024 8-K Director or officer change; Regulation FD disclosure Sep 3, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Director or officer change; Regulation FD disclosure Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change Mar 8, 2024